BaseSpace
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. BRCA1, Response to oxidative stress, Allergy to pollen, Retina, Avian flu virus)
Bookmark Forward

QuickView for nucleolin (gene)


Body Atlas

Most Correlated Tissues

  1. Hematopoietic stem cell of bone marrow
  2. Parotid gland
  3. Peritoneum
  4. B lymphocyte (IgM memory) of spleen
  5. T Lymphocyte (CD4+) of peripheral blood
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Injury of eye region
  2. Perforation of tympanic membrane
  3. Bacterial pneumonia
  4. Effects of heat
  5. Multiple organ dysfunction syndrome
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. 1-amino-2,4-dibromoanthraquinone
  2. N-methylolacrylamide
  3. 4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indacene-3-propionyl ethylene diamine
  4. quintozene
  5. naphthalenediimide
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. MIR365A
  2. H2-Eb2
  3. DNMT3L
  4. HLA-DQA1
  5. BRDT
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Biophysical Characterization of Nucleolin Domains Crucial for Interaction with Telomeric and TERRA G…
  2. Targeting nucleolin improves sensitivity to chemotherapy in acute lymphoblastic leukemia.
  3. Nucleolin in the cell membrane promotes Ang II-mediated VSMC phenotypic switching by regulating the …
  4. Ubiquitination-dependent degradation of nucleolin mediated by porcine circovirus type 3 capsid prote…
  5. Nucleolin promotes angiogenesis and endothelial metabolism along the oncofetal axis in the human bra…
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Dose-escalation Study of Quarfloxin in Patients With Advanced Solid Tumors or Lymphomas
  2. Dose-escalation Study of CX-3543 in Patients With Advanced Solid Tumors or Lymphomas
  3. Hormone Receptor Positive endometrIal Carcinoma Treated by Dual mTORC1/mTORC2 Inhibitor and Anastroz…
  4. Dose-finding Adaptive Phase I/IIa Study to Assess Safety, Tolerability, Pharmacokinetics and Prelimi…
  5. A Study of AS1411 Combined With Cytarabine in the Treatment of Patients With Primary Refractory or R…
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.